Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2024-09-30 Legal Proceedings Report
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
불성실공시법인지정예고 (공시번복)
Legal Proceedings Report Classification · 100% confidence The document is a formal notice from a regulatory body (exchange) regarding the 'designation of an unfaithful disclosure corporation' (불성실공시법인지정예고) due to a disclosure reversal. This is a regulatory notification concerning compliance and legal/regulatory status, which fits the definition of a regulatory filing or legal proceeding update. Since it specifically pertains to regulatory enforcement actions regarding disclosure rules, it falls under the RNS category.
2024-09-30 Korean
기타주요경영사항(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from PharmaResearchBio regarding the termination of a license agreement with LG Chem. It details the contract termination, financial implications (return of down payment), and future strategic plans. Since it is a specific corporate announcement regarding a material business event (contract termination) that does not fit into specific categories like M&A (TAR) or financial reports, it is classified as a general regulatory filing.
2024-08-30 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a short notification (under 1,000 characters) announcing the results of an Investor Relations (IR) event held on May 17, 2024. It provides details about the event's date, location, and participants, and mentions that the presentation materials are available on the Korea Exchange's disclosure system. Since it is a brief announcement regarding the occurrence of an event and the availability of materials rather than the presentation itself, it falls under the Report Publication Announcement (RPA) category.
2024-05-17 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, the election of directors and auditors, and the approval of remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) dated 2024.03.15. It provides a summary of audit opinions and key financial figures (assets, liabilities, revenue, etc.) as reported by the external auditor. Since it is a brief announcement of the audit report submission rather than the full, comprehensive audit report document itself, it falls under the category of a Report Publication Announcement. FY 2023
2024-03-15 Korean
사업보고서 (2023.12)
Interim / Quarterly Report Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for PharmaResearchBio (주식회사 파마리서치바이오) for the fiscal year ending December 31, 2023. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial report, not an announcement or a summary, and it contains the full audited financial data required for an annual financial filing. FY 2023
2024-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.